TY  - GEN
AU  - Schmidt-Hieber,Martin
AU  - Dabrowski,Robert
AU  - Weimann,Andreas
AU  - Aicher,Babette
AU  - Lohneis,Philipp
AU  - Busse,Antonia
AU  - Thiel,Eckhard
AU  - Blau,Igor W
TI  - In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
SN  - 1573-0646
PY  - 2012///0611
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Boronic Acids
KW  - Bortezomib
KW  - Caspase 3
KW  - metabolism
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Synergism
KW  - Flow Cytometry
KW  - HL-60 Cells
KW  - Humans
KW  - Immunohistochemistry
KW  - Inhibitory Concentration 50
KW  - K562 Cells
KW  - Ki-67 Antigen
KW  - Lenalidomide
KW  - Leukemia, Myeloid
KW  - Lymphoma
KW  - Multiple Myeloma
KW  - Phosphorylcholine
KW  - analogs & derivatives
KW  - Pyrazines
KW  - Thalidomide
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-010-9576-2
ER  -